• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

孕激素受体基因表达并不需要孕激素受体CpG岛的去甲基化。

Demethylation of the progesterone receptor CpG island is not required for progesterone receptor gene expression.

作者信息

Ferguson A T, Lapidus R G, Davidson N E

机构信息

Oncology Center, Johns Hopkins University School of Medicine, Baltimore, Maryland 21231, USA.

出版信息

Oncogene. 1998 Aug 6;17(5):577-83. doi: 10.1038/sj.onc.1201961.

DOI:10.1038/sj.onc.1201961
PMID:9704923
Abstract

Progesterone receptor (PR) is an estrogen-stimulated gene which has a CpG island that is heavily methylated in a significant fraction of estrogen receptor (ER)-negative/PR-negative human breast cancers and cell lines, including MDA-MB-231 cells. Treatment of MDA-MB-231 cells with the demethylating agent, 5-aza-2'-deoxycytidine (deoxyC) led to demethylation and expression of ER and PR. However, simultaneous treatment with antiestrogen prevented PR transcription, suggesting that demethylation of PR alone is not sufficient to reactivate the PR gene. To examine the effects of ER on the methylation status of the PR CpG island, we stably transfected MDA-MB-231 cells with an inducible expression vector for ER. Surprisingly, in two cell clones, we found that induction of PR gene expression by ligand-bound ER does not require demethylation of the PR CpG island. In contrast, induction of PR transcription was inhibited by blocking the interaction of ER with SRC-1A, a coactivator of ER function. For the first time, we show that a transcription factor with the potential to remodel heterochromatin can activate gene expression without altering the methylation status of the CpG island. These results raise the possibility that demethylation and histone acetylation are distinct but complementary mechanisms for destabilizing heterochromatin and activating transcription.

摘要

孕激素受体(PR)是一种雌激素刺激基因,其具有一个CpG岛,在相当一部分雌激素受体(ER)阴性/PR阴性的人类乳腺癌及细胞系(包括MDA-MB-231细胞)中该CpG岛高度甲基化。用去甲基化剂5-氮杂-2'-脱氧胞苷(脱氧胞苷)处理MDA-MB-231细胞会导致ER和PR的去甲基化及表达。然而,同时用抗雌激素处理会阻止PR转录,这表明仅PR的去甲基化不足以重新激活PR基因。为了研究ER对PR CpG岛甲基化状态的影响,我们用一个可诱导的ER表达载体稳定转染了MDA-MB-231细胞。令人惊讶的是,在两个细胞克隆中,我们发现配体结合的ER诱导PR基因表达并不需要PR CpG岛的去甲基化。相反,通过阻断ER与ER功能的共激活因子SRC-1A的相互作用,PR转录受到抑制。我们首次表明,一个具有重塑异染色质潜力的转录因子可以在不改变CpG岛甲基化状态的情况下激活基因表达。这些结果增加了这样一种可能性,即去甲基化和组蛋白乙酰化是使异染色质不稳定并激活转录的不同但互补的机制。

相似文献

1
Demethylation of the progesterone receptor CpG island is not required for progesterone receptor gene expression.孕激素受体基因表达并不需要孕激素受体CpG岛的去甲基化。
Oncogene. 1998 Aug 6;17(5):577-83. doi: 10.1038/sj.onc.1201961.
2
Methylation of estrogen and progesterone receptor gene 5' CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors.雌激素和孕激素受体基因5' CpG岛的甲基化与乳腺肿瘤中雌激素和孕激素受体基因表达缺失相关。
Clin Cancer Res. 1996 May;2(5):805-10.
3
Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells.DNA甲基转移酶和组蛋白去乙酰化酶抑制协同激活人雌激素受体α阴性乳腺癌细胞中的功能性雌激素受体α
Cancer Res. 2001 Oct 1;61(19):7025-9.
4
A novel histone deacetylase inhibitor, scriptaid, enhances expression of functional estrogen receptor alpha (ER) in ER negative human breast cancer cells in combination with 5-aza 2'-deoxycytidine.一种新型组蛋白去乙酰化酶抑制剂司立他汀,与5-氮杂-2'-脱氧胞苷联合使用时,可增强雌激素受体α(ER)阴性人乳腺癌细胞中功能性雌激素受体α(ER)的表达。
Breast Cancer Res Treat. 2003 Oct;81(3):177-86. doi: 10.1023/A:1026146524737.
5
Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression.雌激素受体阴性乳腺癌细胞中雌激素受体基因的去甲基化可重新激活雌激素受体基因表达。
Cancer Res. 1995 Jun 1;55(11):2279-83.
6
Progesterone receptor gene inactivation and CpG island hypermethylation in human leukemia cancer cells.人白血病癌细胞中的孕激素受体基因失活与CpG岛高甲基化
FEBS Lett. 2004 Jun 4;567(2-3):327-32. doi: 10.1016/j.febslet.2004.04.044.
7
Estrogen receptor isoform-specific induction of progesterone receptors in human osteoblasts.人成骨细胞中雌激素受体亚型特异性诱导孕激素受体
J Bone Miner Res. 2002 Apr;17(4):580-92. doi: 10.1359/jbmr.2002.17.4.580.
8
Relationship between expression of coactivators and corepressors of hormone receptors and resistance of ovarian cancers to growth regulation by steroid hormones.激素受体共激活因子与共抑制因子的表达与卵巢癌对甾体激素生长调节的抗性之间的关系。
J Soc Gynecol Investig. 2001 Mar-Apr;8(2):104-13.
9
Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.ARHI基因(一种印记肿瘤抑制基因)的异常甲基化和沉默,该基因在乳腺癌中功能丧失。
Cancer Res. 2003 Jul 15;63(14):4174-80.
10
Eliminating epigenetic barriers induces transient hormone-regulated gene expression in estrogen receptor negative breast cancer cells.消除表观遗传障碍可诱导雌激素受体阴性乳腺癌细胞中短暂的激素调节基因表达。
Oncogene. 2008 Jul 3;27(29):4075-85. doi: 10.1038/onc.2008.41. Epub 2008 Mar 3.

引用本文的文献

1
Research progress on estrogen receptor-positive/progesterone receptor-negative breast cancer.雌激素受体阳性/孕激素受体阴性乳腺癌的研究进展
Transl Oncol. 2025 Jun;56:102387. doi: 10.1016/j.tranon.2025.102387. Epub 2025 Apr 14.
2
RNF208, an estrogen-inducible E3 ligase, targets soluble Vimentin to suppress metastasis in triple-negative breast cancers.RNF208,一种雌激素诱导的 E3 连接酶,靶向可溶性波形蛋白以抑制三阴性乳腺癌的转移。
Nat Commun. 2019 Dec 20;10(1):5805. doi: 10.1038/s41467-019-13852-5.
3
Epigenetic targeting in breast cancer: therapeutic impact and future direction.
乳腺癌中的表观遗传靶向治疗:治疗影响与未来方向
Drug News Perspect. 2009 Sep;22(7):369-81. doi: 10.1358/dnp.2009.22.7.1405072.
4
Tamoxifen resistance and epigenetic modifications in breast cancer cell lines.乳腺癌细胞系中的他莫昔芬耐药性与表观遗传修饰
Curr Med Chem. 2007;14(28):3035-45. doi: 10.2174/092986707782794023.
5
Role of DNA methylation and histone acetylation in steroid receptor expression in breast cancer.DNA甲基化和组蛋白乙酰化在乳腺癌类固醇受体表达中的作用。
J Mammary Gland Biol Neoplasia. 2001 Apr;6(2):183-92. doi: 10.1023/a:1011308707512.